New migraine drug tested for fast pain relief
NCT ID NCT06728553
Summary
This study tested whether a medication called MTX101, taken under the tongue, could safely and effectively treat migraine headaches when they occur. Researchers compared MTX101 to a placebo in 78 adults with migraines to see if it reduced pain and the need for additional rescue medications. Participants used the treatment for two separate migraine attacks and tracked their symptoms in a diary.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brainstorm Research
Miami, Florida, 33176, United States
-
Clinical Research Institute, LLC
Santa Monica, California, 90048, United States
-
DelRicht Research
New Orleans, Louisiana, 70115, United States
-
Kaizen Brain Center
La Jolla, California, 92037, United States
-
QUEST Research Institute
Farmington Hills, Michigan, 48334, United States
-
Synergy Clinical Research/Emerald Coast Center for Neurological Disorders
Pensacola, Florida, 32504, United States
-
Wasatch Clinical Research
Salt Lake City, Utah, 84107, United States
Conditions
Explore the condition pages connected to this study.